Comparing Measurements Made in an Incremental Shuttle Walk Test and a Cardiopulmonary Exercise Test in Patients With IPF
A Comparative Assessment of Measurements Made in an Incremental Shuttle Walk Test and Incremental Cycle Ergometry Test in Patients With Idiopathic Pulmonary Fibrosis
1 other identifier
observational
43
1 country
1
Brief Summary
Idiopathic pulmonary fibrosis (IPF) is a chronic and potentially fatal lung disease. As IPF progresses, patients become increasingly breathless with reduced exercise capacity and quality of life. A cardiopulmonary exercise test (CPET) is a gold standard way of assessing patients with IPF. An incremental shuttle walk test is simpler, cheaper, more widely available and anecdotally preferable to CPET. The investigators will compare the measurements made in an ISWT and a CPET in patients with IPF . We aim to determine whether sufficient information can be gathered in an ISWT to negate the need to undertake CPET.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2017
CompletedFirst Posted
Study publicly available on registry
December 2, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedSeptember 27, 2019
September 1, 2019
2.2 years
November 27, 2017
September 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO2 peak
Maximum oxygen consumption at peak exercise
Measured and reported at time of test
Secondary Outcomes (1)
PO2
Measured and reported at time of test
Study Arms (1)
All participants
All patients will be asked to undertake an incremental shuttle walk test and a cardiopulmonary exercise test and the results will be compared.
Eligibility Criteria
Adult patients with a confirmed diagnosis of idiopathic pulmonary fibrosis who are under the care of the Respiratory team at University Hospitals Coventry and Warwickshire NHS Trust.
You may qualify if:
- Diagnosis of idiopathic pulmonary fibrosis confirmed by a multi-disciplinary team.
- Aged 16 or over
- Able to give informed consent to take part
- Able to undertake both a cycle ergometry test and an incremental shuttle walk test without needing walking aids
You may not qualify if:
- An inability to give informed consent.
- Taking part in a research project with a potentially research-modifying intervention
- Currently pregnant.
- Currently breastfeeding.
- Unable to perform an incremental shuttle walk test.
- Unable to perform an incremental cycle ergometry test.
- Unable to walk without an aid such as a stick or frame.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Coventry, Warwickshire, CV2 2DX, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Parr
University Hospitals Coventry and Warwickshire NHS Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2017
First Posted
December 2, 2017
Study Start
January 10, 2018
Primary Completion
April 1, 2020
Study Completion
April 1, 2020
Last Updated
September 27, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share